TY - JOUR
T1 - Impact of Partnership Care Model on Quality of Life in Chronic Diseases
T2 - A Systematic Review and Meta-Analysis
AU - Khoshfetrat, Masoum
AU - Vahedian-Azimi, Amir
AU - Asghari-Jafarabadi, Mohammad
AU - Rahimibashar, Farshid
AU - Reiner, Željko
AU - Jamialahamdi, Tannaz
AU - Sahebkar, Amirhossein
N1 - Funding Information:
Thanks to guidance and advice from the “Clinical Research Development Unit of Baqiyatallah Hospital”.
Publisher Copyright:
© 2023 Bentham Science Publishers.
PY - 2023
Y1 - 2023
N2 - Objective: To evaluate the effectiveness of the Partnership Care Model (PCM) on health-related quality of life (HRQoL) in adults with chronic diseases. Methods Data Sources/Study Setting: Existing literature dealing with the effect of HRQoL on chronic patients according to the HRQoL outcomes based on SF36 question-naires. Study Design: Systematic review and meta-analysis. Data collection: Medline, PubMed, Scopus, Web of Science, Embase, Cochran database and Persian databases, including SID, Magiran, Iranmedex, and Irandoc, were searched according to the MeSH terms until May 15, 2022. Data analysis was made by using the random effects model and heterogeneity by I2 index, and all analyses were made by STA-TA vers.16 (Stata Corp, College Station, Texas, USA). Principal findings: Three studies were included in the meta-analysis. Computing the common effect size, there was a significant intervention effect in all HRQoL dimensions, physical and mental subscales, as well as HRQoL total score. The results showed that there was significantly moderate to high substantial heterogeneity between studies except for vitality (I2 =45.9%, P=0.157) and physical functioning (I2 =30.9%, P=0.235) dimen-sions. Conclusion: According to the results of the study and realizing the efficiency of PCM on the eight dimensions of quality of life of chronic patients, it can be stated that this national model, which is in line with the culture and context of Iran, is effective, simple, effi-cient and reliable. It can be used in the promotion and improvement of various dimensions of HRQoL in chronic diseases.
AB - Objective: To evaluate the effectiveness of the Partnership Care Model (PCM) on health-related quality of life (HRQoL) in adults with chronic diseases. Methods Data Sources/Study Setting: Existing literature dealing with the effect of HRQoL on chronic patients according to the HRQoL outcomes based on SF36 question-naires. Study Design: Systematic review and meta-analysis. Data collection: Medline, PubMed, Scopus, Web of Science, Embase, Cochran database and Persian databases, including SID, Magiran, Iranmedex, and Irandoc, were searched according to the MeSH terms until May 15, 2022. Data analysis was made by using the random effects model and heterogeneity by I2 index, and all analyses were made by STA-TA vers.16 (Stata Corp, College Station, Texas, USA). Principal findings: Three studies were included in the meta-analysis. Computing the common effect size, there was a significant intervention effect in all HRQoL dimensions, physical and mental subscales, as well as HRQoL total score. The results showed that there was significantly moderate to high substantial heterogeneity between studies except for vitality (I2 =45.9%, P=0.157) and physical functioning (I2 =30.9%, P=0.235) dimen-sions. Conclusion: According to the results of the study and realizing the efficiency of PCM on the eight dimensions of quality of life of chronic patients, it can be stated that this national model, which is in line with the culture and context of Iran, is effective, simple, effi-cient and reliable. It can be used in the promotion and improvement of various dimensions of HRQoL in chronic diseases.
KW - chronic diseases
KW - chronic patients
KW - heterogeneity
KW - mental subscales
KW - Partnership-care-model
KW - quality of life
UR - https://www.scopus.com/pages/publications/85150041317
U2 - 10.2174/0929867329666220803122101
DO - 10.2174/0929867329666220803122101
M3 - Article
C2 - 35927802
AN - SCOPUS:85150041317
SN - 0929-8673
VL - 30
SP - 2113
EP - 2120
JO - Current Medicinal Chemistry
JF - Current Medicinal Chemistry
IS - 18
ER -